Press Releases

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,717,500...

Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,550,000...

Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.25 billion of shares of common stock and $1.25 billion of shares of Series B Mandatory...

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended April 3, 2020. All results in this release reflect only continuing operations unless otherwise noted....

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on July 31, 2020 to...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle...

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced today that, due to the public health impact of COVID-19, the Company will hold its 2020 Annual Meeting of Shareholders in a...

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced today that for the quarter ended April 3, 2020 it expects revenue growth of approximately 3.0% and non-GAAP core revenue...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced a reopening of: €150,000,000 principal amount of additional 1.700% senior notes due 2024 at an offering price of...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of: €750,000,000 principal amount of 1.700% senior notes due 2024 at an offering price of 99.931% of...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that the U.S. Federal Trade Commission (the "FTC") has accepted the proposed consent order in connection with Danaher's definitive...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on April 24, 2020 to...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2019. All results in this release reflect only continuing operations unless otherwise...

Danaher Corporation (NYSE: DHR) announced today that it has changed the time for its fourth quarter 2019 conference call and webcast. The call will now begin at 7:30 a.m. ET on Thursday, January...

Danaher Corporation (NYSE: DHR) (the "Company") announced today that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2019...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2019 on Thursday, January 30, 2020 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) announced today the final results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock...

Danaher Corporation (NYSE: DHR) announced today the preliminary results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common...

Danaher Corporation (NYSE: DHR) announced today the final exchange ratio for its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on January 31, 2020 to...

Danaher Corporation (NYSE: DHR) announced today that it will commence an exchange offer related to the split-off of its remaining interest in Envista Holdings Corporation (NYSE: NVST). Envista...

Danaher Corporation (NYSE: DHR) announced today that it has appointed Jessica L. Mega, MD, MPH and Pardis C. Sabeti, MD, D.Phil to its Board of Directors. Dr. Mega is currently Chief Medical and...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International II"), has priced an offering of: $700,000,000...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday,...

Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2019. For the quarter ended September 27, 2019, net earnings attributable to Danaher common stockholders were $648.4...

Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2019 on Thursday, October 24, 2019 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it will redeem all of its $500,000,000 aggregate principal amount of 2.400% Senior Notes due 2020 (the "Danaher 2020 Notes") and...

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its...

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today the pricing of its initial public offering (IPO) of 26,768,000 shares of its common stock at a price...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on October 25, 2019 to...

Danaher Corporation (NYSE: DHR) will host a live video webcast of its Water Quality Platform Investor and Analyst Meeting at Hach on September 17, 2019 beginning at 8:00 a.m. MT. The event will be...

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock. Envista is...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International II"), has priced an offering of:...

Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2019. For the quarter ended June 28, 2019, net earnings were $731.3 million, or $0.97 per diluted share which...

Danaher Corporation (NYSE: DHR) ("Danaher") today announced that Envista Holdings Corporation ("Envista" or the "Company") will be the name of the separate company Danaher intends to create and...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on...

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Rainer Blair, will be presenting at the Bank of...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on July 26, 2019 to...

Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019. For the quarter ended March 29, 2019, net earnings were $333.8 million, or $0.46 per diluted share which...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share payable on April 26, 2019 to holders of record on...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000...

Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.00 per share and 1,500,000...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.35 billion of shares of common stock and $1.35 billion of shares of Series A Mandatory...

Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive agreement with General Electric Company ("GE") (NYSE: GE) to acquire the...

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Joakim Weidemanis, will be presenting at the...

Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2018. For the quarter ended December 31, 2018, net earnings were $746.8 million, or $1.05 per diluted...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2018...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2018 on Tuesday, January 29, 2019 beginning at 8:00 a.m. ET and...

Ahead of its annual investor and analyst meeting to be held in New York City, Danaher Corporation (NYSE: DHR) (the "Company") initiated its 2019 outlook. The Company anticipates that 2019 diluted...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on January 25, 2019 to holders of record on...

Danaher Corporation (NYSE: DHR) will host a live video webcast of its Investor and Analyst Meeting in New York City on December 13, 2018 beginning at 9:30 a.m. ET. A link to the webcast and...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday,...

Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2018. For the quarter ended September 28, 2018, net earnings were $663.7 million, or $0.93 per diluted share which...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2018 on Thursday, October 18, 2018 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) will host a live video webcast of its Mid-Year Investor and Analyst Meeting at Pall on September 18, 2018 beginning at 12:00 p.m. ET. The event will be held at...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on October 26, 2018 to holders of record on...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Morgan Stanley Global Healthcare Conference in New York City...

Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2018. For the quarter ended June 29, 2018, net earnings were $673.8 million, or $0.95 per diluted share which...

Danaher Corporation (NYSE: DHR) today announced its intention to spin off its Dental segment into an independent, publicly-traded company ("DentalCo"). The transaction is intended to be tax-free...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2018 on Thursday, July 19, 2018 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) announced that Daniel L. Comas, Executive Vice President and Chief Financial Officer, and Rainer Blair, Executive Vice President, will be presenting at the...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on July 27, 2018 to holders of record on June 29, 2018.

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Bank of America Merrill Lynch Health Care Conference...

Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2018. For the quarter ended March 30, 2018, net earnings were $566.6 million, or $0.80 per diluted share which...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2018 on Thursday, April 19, 2018 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) (the "Company") and Integrated DNA Technologies ("IDT") announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held...

Danaher Corporation (NYSE: DHR) (the "Company") announced today that it expects first quarter 2018 adjusted diluted net earnings per share to be above the high-end of the Company's previously...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on April 27, 2018 to holders of record on March 29,...

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Barclays Industrial Select Conference in Miami,...

Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2017. For the quarter ended December 31, 2017, net earnings were $856.6 million, or $1.21 per diluted...

Danaher Corporation (NYSE: DHR) today announced that, effective January 1, 2019, Matthew R. McGrew, Group CFO of the Company's Diagnostics and Dental platforms, will succeed Daniel L. Comas as...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2017...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2017 on Tuesday, January 30, 2018 beginning at 8:00 a.m. ET and...

Ahead of its annual investor and analyst meeting to be held in New York City, Danaher Corporation (NYSE: DHR) (the "Company") initiated its 2018 outlook. The Company anticipates that 2018 diluted...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on January 26, 2018 to holders of record on...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility...

Danaher Corporation (NYSE: DHR) will host a live video webcast of its Investor and Analyst Meeting on December 14, 2017 beginning at 9:30 a.m. ET and concluding at approximately 1:00 p.m. The link...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird 2017 Global Industrial Conference in Chicago, Illinois...

Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2017. For the quarter ended September 29, 2017, net earnings were $572.1 million, or $0.81 per diluted share which...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2017 on Thursday, October 19, 2017 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on October 27, 2017 to holders of record on...

Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Vertical Research Partners Industrial Conference in...

Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2017. For the quarter ended June 30, 2017, net earnings were $557.3 million, or $0.79 per diluted share which...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2017 on Thursday, July 20, 2017 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance S.A. ("Danaher International"), has priced an offering of: €250 million principal...

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, and Executive Vice President Rainer Blair will be presenting at the Goldman...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Electrical Products Group Conference in Longboat Key, Florida...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on July 28, 2017 to holders of record on June 30, 2017.

Danaher Corporation (NYSE: DHR) today announced results for the first quarter of 2017. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended...